CAR-T cell therapy is a revolutionary advancement in the field of cell and gene therapy. It empowers a patient’s own immune system to recognize and eliminate cancer cells with remarkable precision.
This therapy involves collecting a patient’s T cells from the blood and reprogramming them in the lab to express special molecules on their surface, chimeric antigen receptors (CARs). These receptors enable the modified T cells to detect and attack cancer cells when reintroduced into the patient’s body.
CAR-T cell therapy has delivered transformative outcomes for patients, particularly in blood cancers, and is being explored across a wide range of solid and hematological malignancies.